Business · 12/07/2018

FDA Releases Draft Guidance for Human Gene Therapy INDs on Chemistry, Manufacturing, and Control Information

The US Food and Drug Administration (FDA) has made available a draft guidance document outlining requirements for Chemistry, Manufacturing, and Control (CMC) information for human gene therapy Investigational New Drug Applications (INDs), aiming to ensure product safety and quality